Steven Cohen Ardelyx, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.44 $1.86 Million - $4.53 Million	-3,147,919 Reduced 62.96%	1,852,081 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$0.51 - $1.17 $2.55 Million - $5.85 Million	5,000,000 New	5,000,000 $2.95 Million
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $516,000 - $1.02 Million	-600,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.27 - $8.17 $762,000 - $4.9 Million	600,000 New	600,000 $792,000
Q4 2020 Feb 16, 2021	SELL	$5.05 - $7.1 $369,109 - $518,946	-73,091 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.25 - $7.08 $383,727 - $517,484	73,091 New	73,091 $384,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.